Speakers

John Berk, Vaishali Sanchorawala, Vaishali Sanchorawala, Shayna Sarosiek

John Berk, MD

Associate Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine, Boston University School of Medicine

Dr. Berk is assistant director of the Amyloidosis Center at Boston University Medical Center. He led the Diflunisal Trial, and has focused on drug development for ATTR amyloidosis for than 15 years. He and his research team have participated in all of the major clinical trials for patients with ATTR amyloid polyneuropathy and cardiomyopathy.

Back to top

Vaishali Sanchorawala, MD

Director, Amyloidosis Center, Boston University School of Medicine

Dr. Sanchorawala is the director of the Amyloidosis Center at Boston University School of Medicine, one of the country’s leading centers for the research and treatment of systemic and localized amyloidosis. She has been involved in the center since 1994 and was appointed director in January 2017. She is a leader in the field of amyloidosis research and is currently running several clinical trials mostly focused on treatment of AL amyloidosis. Dr. Sanchorawala extends her efforts outside of the clinic by participating in research organizations and discussions with the FDA, truly dedicating her career to the advancement of amyloidosis treatment and the well-being of her patients.

Back to top

Vaishali Sanchorawala

Bio information not available at this time.

Back to top

Shayna Sarosiek

Bio information not available at this time.

Back to top